A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. - Wikidata - wikimedia - TriplyDB

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.

http://www.wikidata.org/entity/Q33523445

about

Oncolytic virotherapy for human malignant mesothelioma: recent advances The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma.Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.Novel immunotherapy clinical trials in malignant pleural mesothelioma.A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.Chemotherapy and targeted therapies for unresectable malignant mesothelioma Immunotherapy for ovarian cancer.Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene.Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity.Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.Using macrophage activation to augment immunotherapy of established tumours.Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.Opportunities in immunotherapy of ovarian cancer.The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion Suicide Gene Therapy for Cancer - Current Strategies.Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer Translational advances in pleural malignancies.Gene therapy for mesothelioma.Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions.Immune therapy for ovarian cancer: promise and pitfalls.Malignant pleural effusion: tumor-host interactions unleashed.Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.Gene therapy for malignant mesothelioma: current prospects and challenges.Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.Interventional therapies for malignant pleural effusions: the present and the future.Searching for targets for the systemic therapy of mesothelioma.Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.Switching off malignant pleural effusion formation-fantasy or future?Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.Immunotherapy for malignant mesothelioma: Reality check.Interferon-β lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-β gene transfer to human tumor cells.Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study.Gene therapy for lung cancer malignant pleural effusion: current and future nano-biotechnology.Oncolytic Viral Therapy for Mesothelioma.Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.Intrapleural cisplatin for management of malignant pleural effusion in a patient with plasma cell leucaemia.

P2860

Q26826590-ABE8CC24-0D25-4DFD-A4FA-F309E2D688D4 Q30498202-5378B28E-4410-439F-A13A-F92BD112BD04 Q33556564-369FE6F4-7E99-434D-AC05-E6E05D594CCA Q33871577-282D5A07-BF22-4F1F-8C9F-E1DF659EFA4A Q33923147-C3D17FDE-49D2-4B8A-92EC-F27EFC636C43 Q35042668-1AB1B1BB-9174-4F4C-AD72-CC74D194AF24 Q35141369-1C064457-150D-49DE-BEF0-0BFB9BE9F66F Q35164189-23BCC32C-BE2A-4F05-8DA0-FC58FEDB33E7 Q35175013-77DA319F-51AD-4670-9BD0-3896D8585BFD Q35711576-8AB69D87-D5AB-4A27-8D39-29A5B024286C Q35855798-2B779725-FDED-4230-BC9A-4A88914D96B3 Q35876239-2E80E4FA-85E3-45BC-9CE8-19C415C68756 Q36728254-317DCCE2-DA07-43F8-A708-E6E0EF82FA88 Q36747346-C5ED093E-1C48-43A2-9EF9-783512FFBA46 Q36852170-187FE696-2977-4C78-AFBC-896FC34B59E7 Q36855245-4EC72757-3440-48A4-A8AB-6AC2D60A3C38 Q36907325-B0485C3D-8294-4317-92ED-816C73C218EB Q37347017-EF929211-FC64-47E5-96F6-B56F05E22732 Q37408325-B3278AA0-D98D-4120-96C8-8137FC4BE549 Q37549196-75393961-0DED-429A-B6EE-963FADE41260 Q37806309-5BF947EB-6576-449D-96DB-6B5C487CDB8F Q37868973-93B6939B-F143-4248-BD40-DC2134E03657 Q37872322-B2AD3F6C-4C93-44F5-961C-BFBCDE1A6ED3 Q37873928-91F0EE89-976E-4DD8-A590-7FD24C0FEA7C Q38015001-E61DF39F-4FF6-43F9-B2EB-9B0037E86D04 Q38022486-B3EC86CB-78F8-45CF-BDD7-4BF547525E72 Q38079969-E5C2C26F-06CB-4DA2-9C0C-457D1B468FCB Q38180749-11012BA2-8373-4272-A135-E2BDF672D4CA Q38221769-053B1B8F-15E0-4CE2-9947-B79A86BC90F8 Q38365768-4D1D9037-C5D8-4E76-96DD-F1E3E72052C5 Q38416306-033796BA-F218-4CC9-BCF7-7855182E16A0 Q38543525-94C9969D-7746-461E-A925-1435D3FF67F5 Q38927008-D1CD8527-4355-4FF9-AC4A-7A633A72928F Q39351008-58CD30E7-3465-42F9-B866-60CACC57AB50 Q39354078-DDC47F7E-894C-4E1A-B2DE-7E03E58B8C0F Q39476907-0CE16E2D-22B4-44CE-9F43-504555C9294E Q39511773-FBFFBA49-16DA-40C8-9F66-2C0E9AE98FE7 Q40051845-55F85043-8A92-45E2-B126-4C4A8E7CA9FB Q40127604-752F6DF2-82CC-474B-88DB-9D70D5A826AA Q41507558-76487693-8C39-423A-A7C7-083FAE23A47A

P2860

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.

http://www.wikidata.org/entity/Q33523445

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A phase I trial of repeated in ...... metastatic pleural effusions.

@ast

A phase I trial of repeated in ...... metastatic pleural effusions.

@en

A phase I trial of repeated in ...... metastatic pleural effusions.

@nl

type

label

A phase I trial of repeated in ...... metastatic pleural effusions.

@ast

A phase I trial of repeated in ...... metastatic pleural effusions.

@en

A phase I trial of repeated in ...... metastatic pleural effusions.

@nl

prefLabel

A phase I trial of repeated in ...... metastatic pleural effusions.

@ast

A phase I trial of repeated in ...... metastatic pleural effusions.

@en

A phase I trial of repeated in ...... metastatic pleural effusions.

@nl

P1433

Q33523445-BE04D23C-4415-4FBA-BBEE-166695CD34D6

P1476

Q33523445-711B1F1C-4406-46EE-8769-619BEA6B0311

P2093

Q33523445-1236622E-555B-4BA7-B0F1-27E820F14CF5

Q33523445-1F549F52-BD41-4A48-97B8-C578FCACA252

Q33523445-21321859-1A5A-48C3-921F-8B222CF96D0A

Q33523445-3CA860C5-825E-4216-A912-AA87DD2FEA59

Q33523445-5BC5C769-F5B5-4478-AA04-5FD98A0CF2D0

Q33523445-5DFE2B0A-99FF-40DE-A6E1-E19C4E55A26A

Q33523445-72F26F4D-E4CF-4D43-8A0D-BD12F8F7D38B

Q33523445-7D005FED-5776-4F41-803B-535BC34FB6E1

Q33523445-90360C96-CB77-4C10-B9AB-D43C90C0EB5D

Q33523445-AB7CE6B3-FCC6-4D72-BAF5-E4ACC05F048D

P2860

Q33523445-040D7AEA-0A7D-4F6A-85A1-7F16EDE4FD09

Q33523445-24787D60-57F9-4BBB-BA00-BA747755091E

Q33523445-3779D065-4685-4CC1-BE67-AA8B09F0D93D

Q33523445-410BC1B9-2A81-413E-A841-823385710A9E

Q33523445-44DAC1B2-6A74-4D78-AE3A-7A1CE4D490C1

Q33523445-47509DA8-4105-46A6-BE2A-F8B6DD4AB9EA

Q33523445-4F25AC6D-0C38-4BCB-8B7D-DD7C4974AD3D

Q33523445-5F350EE9-A70E-4B06-A3F0-CB13380F4ECA

Q33523445-606E99C4-BC0E-416F-86CD-9A5ACB48E468

Q33523445-60BCC4F8-DA72-4C8F-9043-45A5FAC5CAB2

P304

Q33523445-C37F018F-5E04-43EC-B7F5-07F8E1610DA0

P31

Q33523445-5C1226EC-A00C-4991-A1A5-8519DB970A99

P356

Q33523445-EF31BAA2-4A35-4874-A488-8432A1F4ED37

P433

Q33523445-2D34CC48-CADC-4B05-977C-3A6DE10DBC88

P478

Q33523445-BD76A8E5-E740-42F2-8721-4B90E43B1CED

P50

Q33523445-5057CDF2-4B26-4341-885C-CB640E432688

Q33523445-6FD427F9-CDC2-4ADF-AFFD-26D888B943FC

P577

Q33523445-1ADA92C5-8528-43C4-A49D-3DFB784BA87D

P5875

Q33523445-5638D702-CABE-4728-9FE4-04558FC659DA

P698

Q33523445-40CE83CB-4CBF-41FA-8A78-F59F445C8FA2

P921

Q33523445-00DE4FE2-783E-4A58-AA7F-4E516F5CEDE9

Q33523445-028446B8-C1AB-4506-B559-2E30406465FD

P932

Q33523445-17CF08A6-2958-4E64-AAA9-C8A2CC557862

P356

P1433

Molecular Therapy

P1476

A phase I trial of repeated in ...... metastatic pleural effusions.

@en

P2093

Adri Recio

http://www.w3.org/2001/XMLSchema#string

Andrew R Haas

http://www.w3.org/2001/XMLSchema#string

Anil Vachani

http://www.w3.org/2001/XMLSchema#string

Carl H June

http://www.w3.org/2001/XMLSchema#string

Colin T Gillespie

http://www.w3.org/2001/XMLSchema#string

Daniel F Heitjan

http://www.w3.org/2001/XMLSchema#string

Edmund Moon

http://www.w3.org/2001/XMLSchema#string

Guanjun Cheng

http://www.w3.org/2001/XMLSchema#string

Jing Sun

http://www.w3.org/2001/XMLSchema#string

Leslie Litzky

http://www.w3.org/2001/XMLSchema#string

P2860

Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Positron emission tomography predicts survival in malignant pleural mesothelioma.

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

Advances in the systemic therapy of malignant pleural mesothelioma.

Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.

The lessons of GIST--PET and PET/CT: a new paradigm for imaging.

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.

P304

852-860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.309

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41001179

http://www.w3.org/2001/XMLSchema#string

P698

20068553

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

2862532

http://www.w3.org/2001/XMLSchema#string